专利号:US-10370455-B2 优先权日:2014-12-05 标题 :Identification of VSIG8 as the putative VISTA receptor (V-R) and use thereof to produce VISTA/VSIG8 agonists and antagonists 发明人:MOLLOY MICHAEL; GUO YALIN; ROTHSTEIN JAY; ROSENZWEIG MICHAEL 权利人:IMMUNEXT INC 摘要:The receptor for VISTA is identified (VSIG8) as well as the use of this receptor in the identification or synthesis of agonist or antagonist compounds, preferably antibodies, polypeptides and fusion proteins which agonize or antagonize the effects of VSIG8 and/or VISTA and/or the VSIG8/VISTA binding interaction. These antagonists may be used to suppress VISTA's suppressive effects on T cell immunity, and more particularly used in the treatment of cancer, or infectious disease. These agonist compounds may be used to potentiate or enhance VISTA's suppressive effects on T cell immunity and thereby suppress T cell immunity, such as in the treatment of autoimmunity, allergy or inflammatory conditions. Screening assays for identifying these agonists and antagonist compounds are also provided.
专利号:US-2023364251-A1 优先权日:2020-08-06 标 题:Methods for the synthesis of protein-drug conjugates 发明人:BORCHARDT ALLEN; HUGHES ROBERT MICHAEL 权利人:CIDARA THERAPEUTICS INC 摘要:The present invention relates to intermediates and methods for synthesizing protein-drug conjugates that can be used for the treatment of diseases and related conditions.
专利号:TW-202220698-A 优先权日:2020-08-06 标题:Methods for the synthesis of protein-drug conjugates
专利号:EP-4192512-A1 优先权日:2020-08-06 标题 :Methods for the synthesis of protein-drug conjugates
专利号:US-2007148246-A1 优先权日:2005-08-11 标题:Nucleic Acid-Based Matrixes 发明人:LUO DAN; LI YOUGEN 权利人:LUO DAN; LI YOUGEN 摘要:Various nucleic acid-based matrixes are provided, comprising nucleic acid monomers as building blocks, as well as nucleic acids encoding proteins, so as to produce novel biomaterials. Methods of utilizing such biomaterials include delivery of biologically active agents, cell and tissue culture, and cell-free protein synthesis.
专利号:US-2019352262-A1 优先权日:2017-02-01 标题 :New Pleuromutilin Antibiotic Compounds, Compositions and Methods of Use and Synthesis 发明人:HERZON SETH; MURPHY STEPHEN K; ZENG MINGSHUO 权利人:UNIV YALE 摘要:The present invention is directed to novel pleuroniutilin antibiotic compounds, intermediates which are useful for making these novel amibioiic compounds and related methods and pharmaceutical compositions for treating pathogens, especially bacterial infections, including gram negative bacteria and synthesizing these compounds.
参考文献:10.1093/ajhp/53.17.2097 摘要:Guglielmo BJ, Jacobs RA. Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin. Am J Health Syst Pharm. 1996 Sep 01;53(17):2097–8. doi: 10.1093/ajhp/53.17.2097. 摘要:Baron TH, Morgan DE, Vickers SM, Lazenby AJ. Organized pancreatic necrosis: endoscopic, radiologic, and pathologic features of a distinct clinical entity. Pancreas. 1999 Jul;19(1):105–8. 摘要:Kobayashi K, Yano S, Kato K, Morita M, Tatsukawa T, Ikeda T, Tokushima T. [A case of M. fortuitum lung disease with small-cell lung cancer]. Nihon Kokyuki Gakkai Zasshi. 2004 May;42(5):424–8. 摘要:Furuya T, Soeno T, Komatsu M. [Strategy for bacterial translocation in acute pancreatitis]. Nihon Shokakibyo Gakkai Zasshi. 2004 May;101(5):502–9. 参考文献:10.1177/1098612x12471526 摘要:Albarellos GA, Denamiel GA, Montoya L, Quaine PC, Lupi MP, Landoni MF. Pharmacokinetics of imipenem after intravenous, intramuscular and subcutaneous administration to cats. Journal of Feline Medicine and Surgery. 2012 Dec 19;15(6):483–7. doi: 10.1177/1098612x12471526.